LAKE FOREST, Ill., Aug. 08, 2023 (GLOBE NEWSWIRE) — Assertio Holdings, Inc. (“Assertio” or the “Company”) (NASDAQ: ASRT), a specialty pharmaceutical company offering differentiated products to patients, announced that effective July 31, 2023, the Compensation Committee of the Company’s Board of Directors granted eight newly-hired employees a total of 82,341…Read More
Assertio Holdings Inc Reports Inducement Grants Under NASDAQ Listing Rule 5635c4
